Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Non-Small Cell Lung Cancer (NSCLC) News Monitoring

Get by Email • RSS

Published on Jun 19, 2025

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer and the second most common cause of cancer-related mortality in men and women. Treatment has significantly advanced over the past few decades, leading to improved outcomes and better …

Source: Pharmacy Times - Neutral
Published on Jun 19, 2025

Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer

Who Is This Drug Approved for? Durvalumab (Imfinzi) is a PD-L1–blocking antibody that has 3 indications for non–small cell lung cancer (NSCLC). All Approved Indications and Timeline February 2018: Received approval for treatment of patients with stage III …

Source: Oncology Nursing News - Pending
Published on Jun 19, 2025

Dato-DXd Combination Is Effective in Post-TKI NSCLC

Xiuning Le, MD, PhD Associate Professor Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston, TX For patients with EGFR-mutated non–small cell lung cancer (NSCLC) who have progressed on …

Source: Targeted Oncology - Pending
Published on Jun 19, 2025

Dr Loong on Sevabertinib in HER2-Mutant NSCLC: SOHO-01 Trial Insights

HER2-mutant non–small cell lung cancer (NSCLC) presents a significant unmet need in oncology, particularly concerning targeted therapeutic options. While advancements have been made in other oncogenic drivers like EGFR, ALK, and ROS1, the landscape for …

Source: Targeted Oncology - Pending
Published on Jun 19, 2025

Is It Worth Adding Chemo to ICI for NSCLC in Older Adults?

Immune checkpoint inhibitors (ICI) are a cornerstone of non-small cell lung cancer (NSCLC) treatment, but it’s not clear whether adding chemotherapy to ICI — a common practice with younger patients with NSCLC — helps older ones. No randomized trial has …

Source: Medscape - Neutral
Published on Jun 19, 2025

Telisotuzumab Vedotin Maintains Efficacy Across Key Subgroups in Pretreated NSCLC With c-MET Overexpression

Data from an analysis of the phase 2 LUMINOSITY trial (NCT03539536) demonstrated that telisotuzumab vedotin-tllv (Emrelis) was active in patients with c-MET protein–overexpressing non–small cell lung cancer (NSCLC) regardless of prior therapy, further …

Source: OncLive - Pending
Published on Jun 19, 2025

Non-Small-Cell Lung Cancer Market Size Set for Rapid Expansion, Valued at USD 36.9 billion by 2031 | CAGR of 9.3%

The non-small cell lung cancer market grow at a CAGR of around 9.3% from 2021-2031. PORTLAND, OR, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report, titled, "Global Non-Small-Cell Lung Cancer …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on Jun 18, 2025

ASCO 2025: Clinical Impact of New Data in Advanced NSCLC

Isabel Preeshagul, DO, comments on treatment updates in advanced non-small cell lung cancer shared at ASCO 2025, emphasizing their impact on patients. The KRYSTAL-7 study showed that adagrasib combined with pembrolizumab achieved a 43% response rate in …

Source: Medscape - Neutral
Published on 00:55 GMT

Updated Data From Phase 1 Trials Support Shifts in the Lung Cancer Treatment Paradigm

Among the treatments that are slowly moving the needle in the non–small cell lung cancer (NSCLC) and extensive-stage small cell lung cancer (ES-SCLC) treatment landscapes are datopotamab deruxtecan-dlnk (Dato-DXd; Datroway) plus rilvegostomig (formerly …

Source: OncLive - Pending
Published on Jun 19, 2025

Choosing Clinical End Points in China for US Bridging Studies

In the first installment of this 3-part series on the translatability of Chinese drug development data to US regulatory standards, we discussed bridging studies, which are clinical trials designed to assess whether data generated outside the US can be …

Source: OncLive - Pending
Published on Jun 16, 2025

Jujuboside B Inhibits the Proliferation and Migration of Non-Small Cell Lung Cancer H1299 Cells Through Inhibiting PI3K/...

Introduction Lung cancer is a common type of cancer with a high incidence and mortality rate.1 In addition, lung cancer is often the direct cause of death when cancer from other organs spreads and metastasizes to the lungs.2 In clinical practice, non-small …

Source: Dove Medical Press - Neutral
Published on Jun 18, 2025

KRAS G12C-Mutated NSCLC: Current Treatment Paradigms

Introduction and KRAS G12C Mutations in NSCLC This medical discussion focuses on targeted therapeutic approaches for advanced non–small cell lung cancer (NSCLC), specifically examining KRAS and ROS1 pathways. The discussion emphasizes the critical …

Source: OncLive - Pending
Published on Jun 18, 2025

FLAURA2 in the Frontline Management of EGFRm NSCLC: Key Considerations for Patient Selection

Summary of EGFR-Mutated NSCLC Frontline Management Discussion The management landscape for advanced EGFR-mutated non–small cell lung cancer (NSCLC) has evolved significantly, with 3 primary frontline treatment options now available for patients with …

Source: OncLive - Pending
Published on Jun 18, 2025

Evaluating Efficacy Outcomes of TKI Therapies in KRAS G12C-Mutated NSCLC

Second-Line KRAS G12C Inhibitors: Adagrasib and Sotorasib Two FDA-approved KRAS G12C inhibitors are currently available for second-line treatment: adagrasib and sotorasib. The CodeBreak 200 study demonstrated sotorasib's efficacy versus docetaxel in …

Source: OncLive - Pending
Published on Jun 19, 2025

Registration Now Open for Our National Caregivers Self-Care Webinar Hosted by the End Brain Cancer Initiative

Registration Now Open for Our National Caregivers Self-Care Webinar Hosted by the End Brain Cancer Initiative REDMOND, WA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@EndBrainCancer. …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...
Published on Jun 18, 2025

Intentional Treatment Sequencing Strategies Optimize SCLC and NSCLC Management

Emerging lung cancer data presented at the 2025 ASCO Annual Meeting signal a paradigm shift toward more targeted, synergistic treatment strategies, with trials such as the phase 3 DeLLphi-304 (NCT05740566) and CheckMate 816 (NCT02998528) studies …

Source: OncLive - Pending
Published on Jun 19, 2025

GI Innovation wins US patent for dual-action IL-2 therapy targeting cold tumors

GI Innovation has secured U.S. patent protection for GI-108, its fourth-generation immunocytokine that targets CD73-driven tumors, where adenosine buildup suppresses immune responses and undercuts immunotherapy. The company said Wednesday it received a …

Source: Korea Biomedical Review - Neutral
Published on Jun 17, 2025

EGFR-mutated NSCLC: Evolving Treatment Landscape

At ASCO 2025, experts in thoracic oncology gathered to discuss advances in EGFR-mutant non-small cell lung cancer (NSCLC), particularly first-line treatment strategies. Patients with EGFR mutations often present with unique characteristics—many are younger …

Source: OncLive - Pending
Published on Jun 17, 2025

LUMINOSITY Data Continue to Highlight Utility of Telisotuzumab Vedotin in c-MET–Overexpressing NSCLC

By leveraging a unique mechanism of action to target c-MET, telisotuzumab vedotin-tllv (Emrelis) represents an additional therapeutic option for patients with c-MET–overexpressing, nonsquamous advanced non–small cell lung cancer (NSCLC), according to …

Source: OncLive - Pending

12 days 08:06:58

Featured Releases

Got News to Share? · Submit · See All

Published on June 19, 2025 - 15:53 GMT

Non-Small-Cell Lung Cancer Market Size Set for Rapid Expansion, Valued at USD 36.9 billion by 2031 | CAGR of 9.3%

The non-small cell lung cancer market grow at a CAGR of around 9.3% from 2021-2031. PORTLAND, OR, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report, titled, "Global Non-Small-Cell Lung Cancer …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 13:37 GMT

Registration Now Open for Our National Caregivers Self-Care Webinar Hosted by the End Brain Cancer Initiative

Registration Now Open for Our National Caregivers Self-Care Webinar Hosted by the End Brain Cancer Initiative REDMOND, WA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@EndBrainCancer. …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on June 19, 2025 - 08:56 GMT

Global Pneumoconiosis Market To Reach $7.62 Billion By 2029 With A Growth Rate Of 8.0%.

The Business Research Company's Pneumoconiosis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /⁨EINPresswire.com⁩/ -- What Growth Has The Pneumoconiosis …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 17, 2025 - 12:45 GMT

Global Lung Cancer Treatment Market Size, Trends, Growth Forecast 2025–2033 | DataM Intelligence

The Global Lung Cancer Treatment Market is expected to reach at a CAGR of 9.5% during the forecast period 2025-2033. AUSTIN, TX, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- The Global Lung Cancer Treatment Market, valued at USD 32.64 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 19, 2025 - 08:15 GMT

Immunotherapy Drugs Market Outlook 2025–2032: Growing Applications in Oncology to Drive beyond USD 398.16 Bn by 2032

BURLINGAME, CA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Global Immunotherapy Drugs Market is estimated to be valued at USD 185.72 Bn in 2025 and is expected to reach USD 398.16 Bn by 2032, exhibiting a compound annual growth rate (CAGR …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 20:12 GMT

Air pollution linked to 30,000 UK deaths in 2025 and costs the economy and NHS billions, warns Royal College of ...

The RCP has warned that air pollution affects almost every organ in the human body, estimated to contribute to the equivalent of 30,000 deaths in the UK in 2025 and cost more than £27 billion annually. The new report from the RCP highlights studies in the …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 19, 2025 - 14:15 GMT

Exosome Research Market is expected to generate a revenue of USD 646.52 Million by 2032, Globally, at 13.93% CAGR: ...

Lewes, Delaware, June 19, 2025 (GLOBE NEWSWIRE) -- The Global Exosome Research Market Size is projected to grow at a CAGR of 13.93% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market was …

Distribution channels: Business & Economy, Media, Advertising & PR ...
Published on June 19, 2025 - 01:06 GMT

UChicago cancer experts showcase leadership and innovation at the 2025 ASCO Annual Meeting

Nearly 25 researchers from the University of Chicago Medicine Comprehensive Cancer Center presented advances in cancer care at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held at McCormick Place in Chicago from May 30 to June 3. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 823,924,138 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 06/17/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 19, 2025 - 21:43 GMT

LATAM Women's HSDD Treatment Market Sees Steady Growth to $170 Million (3.8% CAGR)

Hyposexual desire disorder (HSDD) in women is defined as deficiency or lack of sexual fantasies and desire of sexual activity. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research recently said "LATAM …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 21:42 GMT

Antifibrinolytic Drugs Market: Major Growth & Business Opportunities with Akorn, Bayer, Mylan, Pfizer

Antifibrinolytic drugs are used to prevent fibrinolysis or lysis of blood clots or thrombus. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- The Antifibrinolytic Drugs Market size was estimated at $13.59 billion in 2018 and is …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 21:41 GMT

10.0% CAGR Fuels Top 10 Cancer Drugs Market to $198.8 Billion by 2032

The top 10 cancer drugs market size is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% from 2023 to 2032. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report, titled, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 21:36 GMT

Global Cough Remedies Market to Expand Rapidly as Cold and Flu Cases Rise | Projected to Reach $9.91 Billion by 2030

The global Cough Remedies market size was valued at $7084.5 million in 2020, and is projected to reach $9911.2 million by 2030, registering a CAGR of 3.4%. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- According to the report …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 21:36 GMT

The Artificial Intelligence in Medicines Market Is Set to Reach $18,119 Million | CAGR of 49.6%

The global artificial intelligence in medicines market was valued at $719 million in 2022 and is estimated to reach $18,119 million at a CAGR of 49.6%. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- The global Artificial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 21:35 GMT

Parkinson's disease Drug Market | Forecasted to Cross Valuation of $10.4 Billion by 2031

The global Parkinson's disease drugs market size is projected to reach $10.4 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Parkinson's disease (PD) drug …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 20:30 GMT

Productive Dentist Academy Announces First Clinical Calibration™ Institute Mastermind

New Program Tackles Inconsistent Patient Care & Low Case Acceptance with Team-based Training, Now for $595/Month with Founders Promo ANACORTES, WA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- A lack of alignment among doctors and …

Distribution channels: Business & Economy, Companies ...
Published on June 19, 2025 - 20:18 GMT

Immune Cell Therapy Market Set to Witness Significant Growth by 2025-2032 | Novartis, Autolus, Bluebird Bio, Cellectis

BURLINGAME, CA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- The latest research study released by Coherent Market Insights on "Immune Cell Therapy Market 2025 Forecast to 2032" research provides accurate economic, global, and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 20:16 GMT

Slidell Dental Clinic Outlines Key Differences Between Bonding, Veneers, and Crowns for Cosmetic and Restorative Care

SLIDELL, LA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- As cosmetic dentistry becomes increasingly common among adults seeking both improved function and aesthetics, understanding the distinct purposes of bonding, veneers, and crowns …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 19:37 GMT

Cybersecurity Services Now Available for Small Businesses in Gilbert, Arizona

AZCOMP Technologies expands cybersecurity offerings in Gilbert to help small businesses protect against evolving digital threats. MESA, AZ, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- AZCOMP Technologies, a leading IT services provider based in …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 19:35 GMT

Wellbridge Addiction Treatment and Research Eases the Transition Into Treatment with Compassionate Admissions Process

NEW YORK, NY, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Entering addiction treatment for the first time can be a daunting and emotional experience. Wellbridge NYC Drug & Alcohol Rehab, a premier provider of evidence-based addiction …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 19, 2025 - 19:26 GMT

The Future of Medicine Arrives: Gene Matrix Launches Revolutionary AI-Powered Cancer and PGx Tests in Slovenia

Chicago-based AI-genomics leader introduces its pioneering GeneCancer™ and GenePGx™ tests to the European market, starting with a strategic launch in Slovenia. CHICAGO, IL, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- In a landmark move …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 18:44 GMT

Australia Pathology Lab Services Market 2025: Size, Share, Report | 2033

Australia pathology lab services market size reached USD 10,763.64 Million 2024, is expected USD 24,865.65 Million 2033, growing at a CAGR of 9.75% 2025-2033. LAZIO, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- The latest report by IMARC …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on June 19, 2025 - 18:42 GMT

New Wave in gMG Care: Cutting‑Edge Biologics Transform Treatment Landscape | Competitive Intelligence

Biologics revolutionize generalized myasthenia gravis care with fast-acting, patient-friendly therapies and a robust global pipeline redefining outcomes. AUSTIN, TX, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Generalized Myasthenia …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 18:10 GMT

Clear Skin, Clear Confidence: Dr. Brooke Jeffy Offers Expert Acne Solutions for Teens and Adults in Scottsdale

SCOTTSDALE, AZ, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Acne is one of the most common skin concerns affecting both teenagers and adults alike. From hormonal fluctuations to lifestyle and nutritional triggers, acne is a multifaceted …

Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 18:00 GMT

VisionMed Appoints Dr. Frantz Lerebours as Medical Advisor for AI-Powered Surgical Video Analysis Platform

Orthopedic surgeon and Miami Heat team physician joins VisionMed to guide clinical use of AI-powered surgical video analysis platform EMMA™ MIAMI, FL, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- VisionMed, an AI healthcare innovator …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 17:53 GMT

Seeing Beyond Sight: New Frontiers in AMD Treatment-Gene Therapy and Biosimilars Take Center Stage | CI Intelligence

Pioneering AMD therapies-gene therapy, biosimilars, long‑acting biologics-promise durable vision gains and reduced injection burden for aging populations. AUSTIN, TX, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Revolutionizing AMD Care: …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 17:32 GMT

Multiple Myeloma Market Poised for Breakthrough: Innovation, Unmet Needs, and Strategic Moves | Competitive Intelligence

Explore the evolving Multiple Myeloma market: drug innovations, emerging therapies, and key players driving the next-gen treatment revolution. AUSTIN, TX, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Redefining Multiple Myeloma: …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 19, 2025 - 17:29 GMT

Major Driver in Personalized Psychiatry Global Market: Increasing Mental Health Issues Fueling The Growth Of The Market

The Business Research Company’s Personalized Psychiatry Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on June 19, 2025 - 17:13 GMT

Biosimilars Redefining Therapeutic Access: US & EU Markets on the Brink of $171 Billion Revolution | DataM Intelligence

Biosimilars surge with interchangeable approvals, cost savings, and broad pipeline growth, set to hit $171B by 2033. The next wave of drug affordability is here AUSTIN, TX, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Biosimilars Are …

Distribution channels: Healthcare & Pharmaceuticals Industry ...